OX40 agonist (ZhiMeng Biopharma)

N/A

Report date: 2025/03/19 11:44:15
NME

Base Information

Drug NameOX40 agonist (ZhiMeng Biopharma)
Drug Alias NameOX40 costimulator (ZhiMeng Biopharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonists
TargetsTumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Zhimeng Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Zhimeng Biopharma Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A